Nuclear Medicine and Biology · 1998 · 68 citations · 19 references
MedicineNeurosciencePharmacologyMolecular ImagingNeurochemistryNeuropharmacologyBrain ImagingNeurotransmitter ReceptorsPositron Emission TomographyReceptor ImagingFluorine-18 LabelingFluorine-18 RadiopharmaceuticalsIn Vivo Tracer ImagingNicotinic Acetylcholine Receptor ImagingPet RadiopharmaceuticalsPet TracersPositron Emission Tomography Tracer DevelopmentTracer Testing
The in vivo brain regional distribution of 2-[18F]fluoro-A-85380, a novel tracer for positron emission tomographic (PET) studies, followed the regional densities of brain nAChRs reported in the literature. Evidence of binding to nAChRs and high specificity of the binding in vivo was demonstrated by inhibition with nAChR selective ligands as well as with unlabeled 2-fluoro-A-85380. A preliminary toxicology study of the 2-fluoro-A-85380 showed a relatively low biological effect. 2-[18F]Fluoro-A-85380 holds promise as a useful radiotracer for imaging of nAChRs with PET.
19
Nicotinic acetylcholine binding sites in Alzheimer's disease
Peter J. Whitehouse, Andrea M. Martino, Piero Antuono et al. · Brain Research · 1986 · 485 citations
James P. Sullivan, Diana L. Donnelly‐Roberts, Clark A. Briggs et al. · Neuropharmacology · 1996 · 137 citations · Full text